Literature DB >> 2839687

Antigenicity, function, and conformation of synthetic oligopeptides corresponding to amino-terminal sequences of wild-type and mutant matrix proteins of vesicular stomatitis virus.

J B Shipley1, R Pal, R R Wagner.   

Abstract

The matrix (M) protein of vesicular stomatitis virus (VSV) has a major antigenic determinant (epitope 1) that maps to a region extending from amino acids 19 through 43 and transcription-inhibition activity that maps to the first 43 N-terminal amino acids (J.R. Ogden, R. Pal, and R. R. Wagner, J. Virol. 58:860-868, 1986). The M protein of temperature-sensitive mutant tsO23(III) is devoid of epitope 1 and transcription-inhibition activity and substitutes glutamic acid for glycine at amino acid 21 as well as having amino acid substitutions at positions 111 and 227 (K. Morita, R. Vanderoef, and J. Lenard, J. Virol. 61:256-263, 1987). We undertook to map more precisely epitope 1 and the transcription-inhibition region of VSV M protein by means of synthetic oligopeptides generated by an automated solid-phase protein synthesizer. A pentadecapeptide designated PI(wt, Gly21), corresponding to amino acids 17 to 31 of wild-type (wt) M protein, strongly bound monoclonal antibody MAb2 (directed to epitope 1); however, an analogous pentadecapeptide with glutamic acid substituted for glycine at position 21, designated PII(tsO23, Glu21), completely failed to recognize MAb2. Polyclonal antibody raised in rabbits immunized with PI(wt, Gly21) reacted strongly with wt M protein, the homologous pentadecapeptide, and, to a lesser extent, PII(tsO23, Glu21). Anti-PII(tsO23, Glu21) failed to recognize PI(wt, Gly21) or wt M protein. Anti-PI(wt, Gly21) competed efficiently for binding of MAb2 to wt M protein and was as effective as MAb2 in reversing inhibition of VSV transcription by wt M protein. Neither PI(wt, Gly21) nor PII(tsO23, Glu21) exhibited any ability to inhibit VSV transcription. However, a lysine-rich oligopeptide, PII(Met1-Leu20), corresponding to the first 20 N-terminal amino acids of wt M protein, and polylysine itself did inhibit VSV transcription, albeit much less efficiently than native wt M protein. Monospecific polyclonal antibody directed to the 20-mer oligopeptide PIII(Met1-Leu20) reversed transcription inhibition by M protein in a dose-dependent manner almost identical to that of anti-PI(wt, Gly21) and epitope 1-specific MAb2. Examination by circular dichroism spectropolarimetry revealed significant differences in the conformation of the two pentadecapeptides attributable to the Gly in equilibrium Glu amino acid substitution at position 21.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839687      PMCID: PMC253686          DOI: 10.1128/JVI.62.8.2569-2577.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Inhibition of vesicular stomatitis virus transcriptase complex by the virion envelope M protein.

Authors:  A Combard; C Printz Ane
Journal:  Biochem Biophys Res Commun       Date:  1979-05-14       Impact factor: 3.575

2.  Association of vesicular stomatitis virus glycoprotein with virion membrane: characterization of the lipophilic tail fragment.

Authors:  R H Schloemer; R R Wagner
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

3.  Phenotypic revertants of temperature-sensitive M protein mutants of vesicular stomatitis virus: sequence analysis and functional characterization.

Authors:  K Morita; R Vanderoef; J Lenard
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

4.  The matrix (M) protein of vesicular stomatitis virus regulates transcription.

Authors:  G M Clinton; S P Little; F S Hagen; A S Huang
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

5.  Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus.

Authors:  A R Carroll; R R Wagner
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

6.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody.

Authors:  J M Kelley; S U Emerson; R R Wagner
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

8.  Tests of the helix dipole model for stabilization of alpha-helices.

Authors:  K R Shoemaker; P S Kim; E J York; J M Stewart; R L Baldwin
Journal:  Nature       Date:  1987 Apr 9-15       Impact factor: 49.962

9.  Localization of membrane-associated proteins in vesicular stomatitis virus by use of hydrophobic membrane probes and cross-linking reagents.

Authors:  J J Zakowski; R R Wagner
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

10.  Spatial relationships of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation.

Authors:  E J Dubovi; R R Wagner
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

View more
  9 in total

1.  Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids.

Authors:  P E Kaptur; R B Rhodes; D S Lyles
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Transcription inhibition site on the M protein of vesicular stomatitis virus located by marker rescue of mutant tsO23(III) with M-gene expression vectors.

Authors:  Y Li; L Z Luo; R R Wagner
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides.

Authors:  Z P Ye; N W Baylor; R R Wagner
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  Comparative sequence analysis of the M gene among rabies virus strains and its expression by recombinant vaccinia virus.

Authors:  K Hiramatsu; K Mannen; K Mifune; A Nishizono; Y Takita-Sonoda
Journal:  Virus Genes       Date:  1993-02       Impact factor: 2.332

5.  Effect of vesicular stomatitis virus matrix protein on host-directed translation in vivo.

Authors:  B L Black; G Brewer; D S Lyles
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

6.  The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly.

Authors:  B L Black; R B Rhodes; M McKenzie; D S Lyles
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  Interactions of normal and mutant vesicular stomatitis virus matrix proteins with the plasma membrane and nucleocapsids.

Authors:  L D Chong; J K Rose
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

8.  Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus.

Authors:  Z Ye; W Sun; K Suryanarayana; P Justice; D Robinson; R R Wagner
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  Site-specific mutations in vectors that express antigenic and temperature-sensitive phenotypes of the M gene of vesicular stomatitis virus.

Authors:  Y Li; L Z Luo; R M Snyder; R R Wagner
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.